Therapeutic apheresis

These specialist services remove harmful, disease-forming proteins, chemicals, or cells from patients’ blood

Life-saving patient care

Therapeutic Apheresis is one of our flagship services, and the only one that deals with patients directly. We treat approximately 1,600 adults and children every year from eight dedicated therapeutic units across the country.

The information on these pages is primarily for Therapeutic Apheresis patients, donors, carers and visitors.

If you are a clinician, you may find the following links useful:

Coronavirus (COVID-19) update

We ask that all patients, donors, carers and visitors to our units familiarise themselves with our latest coronavirus update.

Therapeutic Apheresis Services Feedback Survey

If you are a patient, donor, carer or visitor we would like to hear your feedback on our service

Give your feedback

You're in safe hands

  • Our facilities are regulated by the Care Quality Commission, Human Tissue Authority and the Joint Accreditation Committee - ISCT (Europe) & EBMT (JACIE)
  • We have a longstanding exemplary regulatory performance history
  • Each of our units are co-located in NHS Trust environments to provide continuity of care and access to clinical support services

You may also be interested in